Drug - Lanoxin
The trade name of the product as shown on the labeling.
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Multiple ingredients are in alphabetical order.
The potency of the active ingredient(s), Digoxin. May repeat for multiple part products.
The firm name holding legal responsibility for Lanoxin. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
The FDA assigned number to Lanoxin. Format is nnnnnn.
Product Number -
The FDA assigned number to identify Lanoxin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Sep 30, 1997
The date Lanoxin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
The pioneer or innovator of Lanoxin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
The group or category of approved drugs Lanoxin is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Smithkline Beecham Corp Dba Glaxosmithkline
The full name of the firm holding legal responsibility for the new application of Lanoxin.